Literature DB >> 94944

The effect of quipazine and LSD on monoamines in the rat striatum.

M Miśkiewicz, A Rokosz-Pelc, J Vetulani.   

Abstract

Rats given quipazine (5 mg/kg) or LSD (0.05 mg/kg), were decapitated at the time of maximum of behavioral effect of drugs (head twitches), resp. 30 and 15 min, or when the behavioral effects disappeared (resp. 60 and 30 min), and concentrations of dopamine (DA), noradrenaline (NA), serotonin (5HT) and 5-hydroxyindole-3-acetic acid (5-HIAA) were assayed in the striatum. Quipazine significantly elevated the DA level at both periods tested. LSD at the peak of its action depressed the level of 5-HIAA, and in the next period produced a significant depression of striatal levels of NA, 5HT and 5-HIAA.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 94944

Source DB:  PubMed          Journal:  Pol J Pharmacol Pharm        ISSN: 0301-0244


  3 in total

1.  The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced increases in locomotor activity.

Authors:  J J Feigenbaum; J Yanai; H L Klawans
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

2.  The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced locomotor activity.

Authors:  J J Feigenbaum; J Yanai; H L Klawans
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

3.  Methysergide blocks the sleep suppressant action of quipazine in rats.

Authors:  C Fornal; M Radulovacki
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.